0001104659-21-101719.txt : 20210806 0001104659-21-101719.hdr.sgml : 20210806 20210806210102 ACCESSION NUMBER: 0001104659-21-101719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210804 FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Esposito Pamela CENTRAL INDEX KEY: 0001744425 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 211154366 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2124335-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-08-04 0 0001737953 Replimune Group, Inc. REPL 0001744425 Esposito Pamela C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK WOBURN MA 01801 0 1 0 0 Chief Business Officer Common Stock 2021-08-04 4 M 0 4200 15.50 A 214359 D Common Stock 2021-08-04 4 S 0 4200 35.00 D 210159 D Common Stock 2021-08-05 4 M 0 25800 15.50 A 235959 D Common Stock 2021-08-05 4 S 0 25800 35.09 D 210159 D Employee Stock Option (right to buy) 15.50 2021-08-04 4 M 0 4200 0 D 2029-04-01 Common Stock 4200 71550 D Employee Stock Option (right to buy) 15.50 2021-08-05 4 M 0 25800 0 D 2029-04-01 Common Stock 25800 45750 D The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.05. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.38. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,102 shares of the Issuer's common stock, 300,811 of which are exercisable as of the date hereof. 25% of the shares underlying this stock option vested on April 1, 2020, and the remainder of the shares underlying this stock option vested or will vest, as applicable, in 36 approximately equal monthly installments thereafter. /s/ Jean Franchi, attorney-in-fact 2021-08-06